Named Patient Program for Mitomycin for Pyelocalyceal Solution
Conditions: Urothelial Cancer of Renal Pelvis; Urothelial Carcinoma of the Renal Pelvis and Ureter; Urothelial Carcinoma Ureter; Urothelial Carcinoma Ureter Recurrent; Urothelial Carcinoma; Urothelial Carcinoma Recurrent Intervention: Drug: Mitomycin for pyelocalyceal solution Sponsors: UroGen Pharma Ltd.; Tanner Pharma Group Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials